Previsioni del mercato europeo della bioproduzione fino al 2030 - Analisi regionale - per prodotto (prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri), applicazione (artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri) , apparecchiature (apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori) e utente finale (aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri)
La crescente prevalenza delle malattie croniche guida il mercato della bioproduzione in Europa
Le malattie cardiovascolari (CVD), i disturbi neurologici, i disturbi autoimmuni e il cancro sono tra le malattie croniche che causano morte e disabilità a un ritmo significativo in tutto il mondo. Secondo l’Organizzazione Mondiale della Sanità (OMS), le malattie cardiovascolari sono la prima causa di morte a livello globale, mietendo circa 17,9 milioni di vittime ogni anno. Il cancro è anche una delle principali cause di mortalità a livello mondiale, colpendo una popolazione enorme; pertanto, agisce come un enorme onere finanziario per la società. Secondo l’OMS, nel 2020, a livello globale si sono verificati circa 10 milioni di decessi dovuti al cancro. Tuttavia, la crescente ricerca sullo sviluppo di trattamenti efficaci per la malattia sta influenzando positivamente la crescita del mercato. La terapia genica e la terapia cellulare stanno trasformando il panorama della cura del cancro; per esempio, Kymriah di Novartis è usato per trattare il linfoma diffuso a grandi cellule B.
Inoltre, il riconoscimento dei biosimilari come agenti efficaci e sicuri da parte di pazienti, specialisti, medici di base e altri operatori sanitari sta stimolando la domanda di biosimilari. Inoltre, i biosimilari contribuiscono a migliorare la vita di milioni di pazienti, risparmiando miliardi di dollari all’anno al sistema sanitario. Sono opzioni efficaci ed economicamente vantaggiose nel trattamento di molte malattie, comprese le condizioni croniche della pelle e le malattie intestinali come il morbo di Crohn, la psoriasi, la sindrome dell\'intestino irritabile e la colite; diabete; malattia autoimmune; cancro; condizioni renali; e artrite.
Poiché la prevalenza delle malattie croniche sta aumentando a un ritmo elevato, la domanda di bioproduzione per il trattamento di malattie potenzialmente letali è progredita rapidamente negli ultimi cinque anni, guidando così il mercato della bioproduzione.
Panoramica del mercato europeo della bioproduzione
Il mercato europeo della bioproduzione è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. L’Europa occupa una posizione significativa nel mercato globale della bioproduzione e si stima che registrerà un notevole CAGR nel periodo 2022-2030. La crescente prevalenza di disturbi cronici ha comportato un numero crescente di lanci e approvazioni di prodotti, insieme a progressi tecnologici e investimenti, contribuendo così alla crescita del mercato nella regione.
I biosimilari introducono la concorrenza e aumentano l’accessibilità economica dei prodotti biologici, che in ultima analisi offrono risparmi e servizi a valore aggiunto a sostegno della cura dei pazienti e del settore sanitario. Gli operatori sanitari possono trattare più pazienti con farmaci biologici di alta qualità a costi ridotti. Considerato l’enorme potenziale di risparmio sui costi, il Ministero della Sanità tedesco ha introdotto una nuova legge per aumentare l’adozione dei biosimilari. Poiché alcuni paesi dell’Unione Europea (UE) consentono la sostituzione dei farmacisti con i biosimilari, ciò rappresenterebbe un cambiamento significativo nella pratica, in particolare per la Germania. Inoltre, operatori sanitari come il Centro di fisioterapia ortopedica PHI, Clinica internazionale tedesca, Francoforte, Germania; CBC Health Monaco di Baviera, Germania; e altri fornitori offrono terapie con cellule staminali per varie malattie croniche come la retinopatia diabetica, la neurite del nervo ottico e l\'artrite reumatoide. Si prevede che ciò aumenterà l’adozione di terapie cellulari nei prossimi anni. Inoltre, un numero crescente di partnership tra attori internazionali stimola la crescita del mercato. Ad esempio, nel novembre 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC e apceth Biopharma GmbH hanno ampliato il loro rapporto con bluebird bio con accordi a lungo termine di sviluppo e servizi di produzione per la fornitura clinica e commerciale di molteplici terapie, inclusa l\'espansione della capacità di produzione di prodotti farmaceutici commerciali in Europa per ZYNTEGLO, una terapia genica una tantum per la β-talassemia trasfusione-dipendente (TDT). Pertanto, con le crescenti iniziative governative per l’adozione dei biosimilari in Germania, si prevede che il mercato fiorirà.
Entrate e previsioni del mercato europeo della bioproduzione fino al 2030 (milioni di dollari)
Segmentazione del mercato europeo della bioproduzione
Il mercato europeo della bioproduzione è classificato in prodotto, applicazione, attrezzatura, utente finale e paese.
In base al prodotto, il mercato europeo della bioproduzione è segmentato in prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri. Il segmento dei prodotti biologici e biosimilari ha detenuto la quota maggiore del mercato europeo della bioproduzione nel 2022.
In termini di applicazione, il mercato europeo della bioproduzione è segmentato in artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri. Il segmento del cancro ha detenuto la quota maggiore del mercato europeo della bioproduzione nel 2022.
In base alle apparecchiature, il mercato europeo della bioproduzione è suddiviso in apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori. Il segmento dei materiali di consumo e degli accessori ha detenuto la quota maggiore del mercato europeo della bioproduzione nel 2022.
In termini di utente finale, il mercato europeo della bioproduzione è classificato in aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri. Il segmento delle aziende biofarmaceutiche deteneva la quota maggiore del mercato europeo della bioproduzione nel 2022.
Per paese, il mercato europeo della bioproduzione è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. La Germania ha dominato la quota di mercato europea della bioproduzione nel 2022.
Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd e Bio-Rad Laboratories Inc. sono alcune delle aziende leader che operano nel mercato europeo della bioproduzione.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Europe Market Analysis
5.1 Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Europe: Bioproduction Market
10.1.1 Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Germany: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Germany: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Germany: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Germany: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Germany: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 UK: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 UK: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 UK: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 UK: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 UK: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 France: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 France: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 France: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 France: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Italy: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Italy: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Italy: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Italy: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 Spain: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 Spain: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 Spain: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 Spain: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Europe: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Europe: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Europe: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Europe Bioproduction Market Segmentation
Table 2. Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. UK Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. France Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. France Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Spain Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Europe Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Europe Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Europe Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Europe Bioproduction Market Segmentation, By Country
Figure 2. Europe Bioproduction Market: Key Industry Dynamics
Figure 3. Europe Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. bbi-biotech GmbH
2. Bio-Rad Laboratories Inc
3. Danaher Corp
4. F. Hoffmann-La Roche Ltd
5. FUJIFILM Irvine Scientific Inc
6. Lonza Group AG
7. Merck KGaA
8. Sartorius AG
9. Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.